Decision-making in Parkinson's disease patients with and without pathological gambling

Eur J Neurol. 2010 Jan;17(1):97-102. doi: 10.1111/j.1468-1331.2009.02792.x. Epub 2009 Sep 23.

Abstract

Background and purpose: Pathological gambling (PG) in Parkinson's disease (PD) is a frequent impulse control disorder associated mainly with dopamine replacement therapy. As impairments in decision-making were described independently in PG and PD, the objective of this study was to assess decision-making processes in PD patients with and without PG.

Methods: Seven PD patients with PG and 13 age, sex, education and disease severity matched PD patients without gambling behavior were enrolled in the study. All patients were assessed with a comprehensive neuropsychiatric and cognitive evaluation, including tasks used to assess decision-making abilities under ambiguous or risky situations, like the Iowa Gambling Task (IGT), the Game of Dice Task and the Investment Task.

Results: Compared to PD patients without gambling behavior, those with PG obtained poorer scores in the IGT and in a rating scale of social behavior, but not in other decision-making and cognitive tasks.

Conclusions: Low performance in decision-making under ambiguity and abnormal social behavior distinguished PD patients with PG from those without this disorder. Dopamine replacement therapy may induce dysfunction of the ventromedial prefrontal cortex and amygdala-ventral striatum system, thus increasing the risk for developing PG.

MeSH terms

  • Aged
  • Amygdala / drug effects
  • Amygdala / physiopathology
  • Basal Ganglia / drug effects
  • Basal Ganglia / physiopathology
  • Cognition Disorders / chemically induced
  • Cognition Disorders / diagnosis
  • Cognition Disorders / psychology*
  • Decision Making / drug effects
  • Decision Making / physiology
  • Disability Evaluation
  • Disruptive, Impulse Control, and Conduct Disorders / chemically induced
  • Disruptive, Impulse Control, and Conduct Disorders / diagnosis
  • Disruptive, Impulse Control, and Conduct Disorders / psychology*
  • Dopamine / metabolism
  • Dopamine Agents / adverse effects*
  • Female
  • Gambling / psychology*
  • Humans
  • Male
  • Middle Aged
  • Neuropsychological Tests
  • Parkinson Disease / drug therapy*
  • Prefrontal Cortex / drug effects
  • Prefrontal Cortex / physiopathology
  • Social Behavior Disorders / chemically induced
  • Social Behavior Disorders / diagnosis
  • Social Behavior Disorders / psychology
  • Task Performance and Analysis

Substances

  • Dopamine Agents
  • Dopamine